Mode
Text Size
Log in / Sign up
N/A N=35

NIRS Monitoring to Detect AKI in Preterm Infants

Acute Kidney Injury · Premature Infant

Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcome: Primary: Renal NIRS Tissue Oxygenation Differential — 60; 32.4; 62.5; 44.4 percentage saturation — p=<0.001

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Near Infrared Spectroscopy (Device)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
University of Wisconsin, Madison
Primary completion
Dec 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Renal NIRS Tissue Oxygenation Differential
60; 32.4; 62.5; 44.4; 60.4; 30.8 <0.001 sig
SECONDARY
Correlation of Renal NIRS Values to Serum Creatinine
0.81 0.17
SECONDARY
Correlation of Renal NIRS Values to Urine Output
3 0.32
SECONDARY
Baseline Renal NIRS Values Before Caffeine
15.24; 26.93; 36.11; 48.61; 54.41; 73.08
SECONDARY
Renal NIRS Values 1 Hour After Caffeine
16.09; 32.83; 44.18; 49.23; 54.31; 70.55 <0.01 sig
SECONDARY
Renal NIRS Values 2 Hours After Caffeine
16.15; 40.66; 39.06; 49.96; 55.81; 68.51 <0.001 sig
SECONDARY
Renal NIRS Values 3 Hours After Caffeine
17.3; 36.12; 40.4; 50.6; 58.05; 66.55 <0.01 sig
SECONDARY
Renal NIRS Values 4 Hours After Caffeine
16.98; 39.64; 42.71; 48.47; 57.78; 71.19 <0.0001 sig
SECONDARY
Renal NIRS Values 6 Hours After Caffeine
15.4; 35.18; 40.62; 49.97; 55.8; 70.09 <0.05 sig

Summary

This study will examine the relationship of oxygen levels, using Near-infrared spectroscopy (NIRS) monitoring, and kidney injury in infants born prematurely. NIRS is a skin sensor which detects the amount of oxygen going to different organs, most often used to monitor the brain and kidney.

Eligibility Criteria

Inclusion Criteria

  • Preterm infants < 32 weeks
  • Admitted to Unity Point Health(UPH) Meriter Newborn Intensive Care Unit (NICU)
  • Application of NIRS by 48 hours of age

Exclusion Criteria

  • Congenital anomaly of the kidney or urinary tract (CAKUT)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03384173). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search